Clinical Trial Update: Mechanism of Hypertension Treatments in Liver Transplant Recipients (BLOCK LTR-HTN) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating mechanisms of hypertension treatments in liver transplant recipients has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Liver Transplantation

Snippet

Sponsor: Northwestern University | Conditions: High Blood Pressure, Liver Transplant | Phase 4 | Status: WITHDRAWN